Rates of Gender-Affirming Surgery Examined in Cisgender Males, Gender-Diverse

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on July 10, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 10, 2024 -- For adults and minors, most breast reductions performed on cisgender males and transgender and gender-diverse (TGD) people are performed on cisgender males, according to a research letter published online June 27 in JAMA Network Open.

Dannie Dai, from the Harvard T.H. Chan School of Public Health in Boston, and colleagues characterized the relative use of gender-affirming surgeries by TGD and cisgender populations. TGD people who received a gender-affirming procedure were identified; the rate of people who received a gender-affirming procedure with a TGD-related diagnosis per 100,000 total people was calculated for adults or minors. The proportion of breast reductions used by cisgender males without a TGD-related diagnosis and TGD people was compared.

In 2019, 47,437,919 adults who were insured and 22,827,194 minors (16.8, 11.9, and 71.3 percent ages 15 to 17, 13 to 14, and 12 years or younger, respectively) who were insured were included in the sample. The researchers found that the rate of undergoing a gender-affirming surgery with a TGD-related diagnosis was 5.3 per 100,000 total adults compared with 2.1, 0.1, and 0 per 100,000 minors aged 15 to 17, 13 to 14, and 12 years or younger, respectively. Overall, 59.7 and 96.4 percent of gender-affirming surgical procedures identified among adults and minors were chest-related procedures. Eighty percent of the 636 breast reductions among cisgender male and TGD adults were performed on cisgender males; 97 percent of the 151 breast reductions among cisgender male minors and TGD male minors were performed on cisgender male minors.

"These findings suggest that concerns around high rates of gender-affirming surgery use, specifically among TGD minors, may be unwarranted," the authors write. "Low use by TGD people likely reflects adherence to stringent standards of gender-affirming care."

One author disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-11 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords